Table 3.
Patient demographics and baseline clinical characteristics
| Number (%) | |||
|---|---|---|---|
| Pre-selection N = 30 | Post-selection N = 115 | Overall N = 145 | |
| Age (median) | 19–68 (52) | 28–77 (54) | 19–77 (54) |
| Male | 23 (76.7) | 82 (71.3) | 105 (72.4) |
| Nephrectomy | 26 (86.7) | 115 (100) | 141 (97.2) |
| MSKCC risk | |||
| Good | 19 (63.3) | 98 (85.2) | 117 (80.7) |
| Intermediate | 11 (36.7) | 17 (14.8) | 28 (19.3) |
| Poor | 0 | 0 | 0 |
| Heng risk | |||
| Favourable | 7 (23.3) | 60 (52.2) | 67 (46.2) |
| Intermediate | 19 (63.3) | 47 (40.9) | 66 (45.5) |
| Poor | 4 (13.3) | 8 (6.9) | 12 (8.3) |
| Pathology type | |||
| Favourable | 17 (56.7) | 106 (92.2) | 123 (84.8) |
| Other | 13 (43.3) | 9 (7.8) | 22 (15.2) |
| No of met organ(s) | |||
| 1 | 10 (33.3) | 42 (36.5) | 52 (35.9) |
| 2 | 7 (23.3) | 41 (35.7) | 48 (33.1) |
| 3 + | 13 (43.3) | 32 (27.8) | 45 (31.0) |